Global Encephalopathy Treatment Market 2019-2023

脳症治療の世界市場2019-2023

◆タイトル:Global Encephalopathy Treatment Market 2019-2023
◆商品コード:IRTNTR30076
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2018年10月30日
◆ページ数:104
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥378,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、脳症治療の世界市場について調査・分析し、市場概要、市場環境、脳症治療市場規模、種類別(肝性脳症、糖尿病性脳症、感染性脳症、その他)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・脳症治療の世界市場概要
・脳症治療の世界市場環境
・脳症治療の世界市場動向
・脳症治療の世界市場規模
・脳症治療の世界市場:業界構造分析
・脳症治療の世界市場:種類別(肝性脳症、糖尿病性脳症、感染性脳症、その他)
・脳症治療の世界市場:地域別市場規模・分析
・脳症治療の北米市場規模・予測
・脳症治療のヨーロッパ・中東・アフリカ市場規模・予測
・脳症治療のアジア太平洋市場規模・予測
・脳症治療の主要国分析
・脳症治療の世界市場:意思決定フレームワーク
・脳症治療の世界市場:成長要因、課題
・脳症治療の世界市場:競争環境
・脳症治療の世界市場:関連企業情報(ベンダー分析)

About Encephalopathy
Encephalopathy is a disease that affects the functioning and structure of the brain. It can be temporary, permanent, or neonatal.
Technavio’s analysts forecast the Global Encephalopathy Treatment Market to grow at a CAGR of 4.75% during the period 2019-2023.

Covered in this report
The report covers the present scenario and the growth prospects of the encephalopathy treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of encephalopathy across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, encephalopathy treatment market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendor
• Bausch Health
Market driver
• Rise in initiatives to increase the awareness about encephalopathy disease management
• For a full, detailed list, view our report

Market challenge
• Adverse effects associated with available drugs
• For a full, detailed list, view our report

Market trend
• Emergence of novel treatment targets for encephalopathy
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: PIPELINE ANALYSIS
• Pipeline Analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Hepatic encephalopathy – Market size and forecast 2018-2023
• Diabetic encephalopathy – Market size and forecast 2018-2023
• Infectious encephalopathy – Market size and forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Emergence of novel treatment targets for encephalopathy
• Increase in FDA drug approval for diseases associated with encephalopathy
• Increase in adoption of technological advances for treating encephalopathy
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Market positioning of vendors
• Bausch Health
PART 15: APPENDIX
• Research methodology
• List of abbreviations
PART 16: EXPLORE TECHNAVIO


Exhibit 01: Global CNS disorder drugs market
Exhibit 02: Segments of global cns disorder drugs market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Pipeline drugs under phase I/II development
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Type – Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Hepatic encephalopathy – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Hepatic encephalopathy – Year-over-year growth 2019-2023 (%)
Exhibit 22: Diabetic encephalopathy – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Diabetic encephalopathy – Year-over-year growth 2019-2023 (%)
Exhibit 24: Infectious encephalopathy – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Infectious encephalopathy – Year-over-year growth 2019-2023 (%)
Exhibit 26: Others – Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Others – Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by type
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in Americas
Exhibit 35: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in EMEA
Exhibit 38: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 39: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in APAC
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Bausch Health – Vendor overview
Exhibit 50: Bausch Health – Business segments
Exhibit 51: Bausch Health – Organizational developments
Exhibit 52: Bausch Health – Geographic focus
Exhibit 53: Bausch Health – Segment focus
Exhibit 54: Bausch Health – Key offerings



【掲載企業】

Bausch Health

★調査レポート[脳症治療の世界市場2019-2023] (Global Encephalopathy Treatment Market 2019-2023 / IRTNTR30076)販売に関する免責事項
[脳症治療の世界市場2019-2023] (Global Encephalopathy Treatment Market 2019-2023 / IRTNTR30076)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆